FDA Funding Cuts: US Healthcare at Risk
- since January 2025, the Trump administration has initiated a series of actions that pose a direct threat to health care, affecting both U.S.
- Initially, severe cuts to development aid disrupted medicine supply chains and numerous health programs in African and other low-income countries.
- Ample job losses across agencies, including the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH), are...
The Trump administration’s health cuts, implemented since January 2025, put US healthcare at important risk, jeopardizing global health initiatives and the nation’s infrastructure. severe cuts to development aid have disrupted crucial medicine supply chains, alongside job losses at the FDA and other key agencies. These actions threaten the vital role of the US in public health, directly affecting patients and the global community. News Directory 3 reports on the unfolding consequences and the long-term threats to healthcare systems. Discover what’s next in this critical situation.
Trump Administration Health Cuts Threaten Global Health, US Infrastructure
Updated June 26, 2025
since January 2025, the Trump administration has initiated a series of actions that pose a direct threat to health care, affecting both U.S. and global citizens. The administration’s policies play a meaningful role in the stability of healthcare systems.
Initially, severe cuts to development aid disrupted medicine supply chains and numerous health programs in African and other low-income countries. This has since expanded into a broader retrenchment of the U.S.’s health infrastructure.
Ample job losses across agencies, including the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH), are negatively impacting patients. The cuts affect the agencies’ ability to fulfill their role in public health.
What’s next
The long-term consequences of these actions remain to be seen, but experts worry about the lasting damage to global health initiatives and the U.S. health infrastructure.